LGALS3 and arrhythmogenic right ventricular cardiomyopathy: An interesting study in adult patients with arrhythmogenic right ventricular cardiomyopathy by Oz et al. [44] and implanted defibrillators adds to the evidence for galectin-3 being useful in the risk stratification of arrhythmias.